Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts

Damian C Genetos1, Chrisoula A Toupadakis, Leah F Raheja

  • 1Department of Surgical and Radiological Sciences, School of Veterinary Medicine, UC Davis, Davis, California 95616, USA. dgenetos@ucdavis.edu

Insights

Cellular hypoxia decreases sclerostin expression by inhibiting Wnt/Lrp5 signaling. This finding offers new insights into bone development and sclerosing bone dysplasias, impacting bone mineral density.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Bone Biology

Background:

  • Sclerostin mutations cause sclerosing bone dysplasias by reducing Wnt/Lrp5 signaling antagonism.
  • VHL tumor suppressor deletion in osteoblasts increases bone mass via HIF-alpha stabilization.
  • The role of cellular oxygen levels on sclerostin and Wnt signaling requires further investigation.

Purpose of the Study:

  • To investigate the impact of cellular hypoxia on sclerostin expression and canonical Wnt signaling.
  • To elucidate the molecular mechanisms linking oxygen levels to sclerostin regulation.

Main Methods:

  • Osteoblasts and osteocytes were cultured under hypoxic conditions (1% oxygen).
  • Sclerostin transcript and protein levels were measured.
  • Beta-catenin expression, nuclear localization, and gene reporter activity were assessed.
  • Expression of BMP antagonists (gremlin, noggin) and Smad phosphorylation were analyzed.
  • MEF2 and VEGF signaling pathways were modulated and analyzed.

Main Results:

  • Hypoxia significantly decreased sclerostin transcript and protein levels in osteoblasts and osteocytes.
  • Hypoxia and DFO (hypoxia mimetic) increased beta-catenin expression and nuclear localization.
  • Hypoxia increased BMP antagonists (gremlin, noggin) and decreased Smad-1/5/8 phosphorylation.
  • MEF2 reporter activity decreased under hypoxia, suggesting a role in sclerostin regulation.
  • VEGF signaling modulation did not affect Sost transcription under normoxia or hypoxia.

Conclusions:

  • Cellular hypoxia inhibits sclerostin expression.
  • This inhibition is mediated through enhanced antagonism of BMP signaling, independently of VEGF.
  • Findings suggest a novel regulatory mechanism for sclerostin by oxygen levels, impacting Wnt signaling pathways.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...